Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?

Journal of Proteome Research

Volumn 10, Issue 10, 2011, Pages 4405-4415

  Klose, Patricia ^a   Weise, Christoph ^a   Bondzio, Angelika ^a   Multhaup, Gerd ^a   Einspanier, Ralf ^a   Gruber, Achim D ^a   Klopfleisch, Robert ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

breast cancer; canine mammary tumor; malignancy; malignant progression; metastasis

Indexed keywords

ACTIN; ADENOSINE DEAMINASE; ALPHA TROPOMYOSIN; CALRETININ; CYCLINE; CYTOKERATIN 17; CYTOKERATIN 19; CYTOKERATIN 8; ELONGATION FACTOR 1; FERRITIN; FIBRINOGEN; GELSOLIN; HEMOPEXIN; ISOCITRATE DEHYDROGENASE; LIPOCORTIN 5; MYOSIN LIGHT CHAIN 2; ORNITHINE OXOACID AMINOTRANSFERASE; PEROXIREDOXIN; PEROXIREDOXIN 6; PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHOGLYCERATE MUTASE; PROLINE DIPEPTIDASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; THIOREDOXIN; TROPOMYOSIN; VINCULIN;

ADENOMA; ANIMAL TISSUE; ARTICLE; BREAST METASTASIS; CANCER GROWTH; CONTROLLED STUDY; DOG; DOWN REGULATION; MAMMARY GLAND; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ADENOMA; ANIMALS; CARCINOMA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOGS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM METASTASIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 80053930592     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200112q     Document Type: Article

References (42)

1. Klopfleisch, R.; von Euler, H.; Sarli, G.; Pinho, S. S.; Gartner, F.; Gruber, A. D. Molecular carcinogenesis of canine mammary tumors: news from an old disease. Vet. Pathol. 2010, not supplied.
2. Lin, S. X.; Chen, J.; Mazumdar, M.; Poirier, D.; Wang, C.; Azzi, A.; Zhou, M. Molecular therapy of breast cancer: progress and future directions Nat. Rev. Endocrinol. 2010, 6 (9) 485-93
3. McGavin, M. D.; Zachary, J. F. Pathologic Basis of Veterinary Disease, 4 th ed.; Mosby: St. Louis, MO, 2007; p 1476.
4. Alkarain, A.; Slingerland, J. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer Breast Cancer Res. 2004, 6 (1) 13-21 (Pubitemid 38195556)
5. Klopfleisch, R.; Klose, P.; Weise, C.; Bondzio, A.; Multhaup, G.; Einspanier, R.; Gruber, A. D. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer J, Proteome Res, 2010, 9 (12) 6380-91
6. Klopfleisch, R.; Lenze, D.; Hummel, M.; Gruber, A. D. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas. Vet. J. 2010, not supplied.
7. Klopfleisch, R.; Lenze, D.; Hummel, M.; Gruber, A. D. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles BMC Cancer 2010, 10, 618
8. Weigelt, B.; Peterse, J. L.; van 't Veer, L. J. Breast cancer metastasis: markers and models Nat. Rev. Cancer 2005, 5 (8) 591-602 (Pubitemid 41081385)
9. Sorenmo, K. U.; Kristiansen, V. M.; Cofone, M. A.; Shofer, F. S.; Breen, A. M.; Langeland, M.; Mongil, C. M.; Grondahl, A. M.; Teige, J.; Goldschmidt, M. H. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence Vet. Comp. Oncol. 2009, 7 (3) 162-72
10. Misdorp, W.; Else, R. W.; Hellmén, E.; Lipscomb, T. P. Histological classification of mammary tumors of the dog and the cat; Armed Forces Institute of Pathology: Washington, D.C., 1999; Vol. 7, pp 19-22.
11. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal. Chem. 1996, 68 (5) 850-8
12. Suckau, D.; Resemann, A.; Schuerenberg, M.; Hufnagel, P.; Franzen, J.; Holle, A. A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics Anal. Bioanal. Chem. 2003, 376 (7) 952-65 (Pubitemid 40877913)
13. Ren, F.; Wu, H.; Lei, Y.; Zhang, H.; Liu, R.; Zhao, Y.; Chen, X.; Zeng, D.; Tong, A.; Chen, L.; Wei, Y.; Huang, C. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma Mol. Cancer 2011, 9, 81
14. Durany, N.; Joseph, J.; Jimenez, O. M.; Climent, F.; Fernandez, P. L.; Rivera, F.; Carreras, J. Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma Br. J. Cancer 2000, 82 (1) 20-7 (Pubitemid 30008953)
15. Sahoo, S. K.; Kim do, H. Characterization of calumenin in mouse heart BMB Rep. 2011, 43 (3) 158-63
16. Ding, S. J.; Li, Y.; Shao, X. X.; Zhou, H.; Zeng, R.; Tang, Z. Y.; Xia, Q. C. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials Proteomics 2004, 4 (4) 982-94 (Pubitemid 38445958)
17. Wu, W.; Tang, X.; Hu, W.; Lotan, R.; Hong, W. K.; Mao, L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry Clin. Exp. Metastasis 2002, 19 (4) 319-26 (Pubitemid 34606757)
18. Sorenmo, K. U.; Rasotto, R.; Zappulli, V.; Goldschmidt, M. H. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms Vet. Pathol. 2011, 48 (1) 85-97
19. Xia, Q.; Kong, X. T.; Zhang, G. A.; Hou, X. J.; Qiang, H.; Zhong, R. Q. Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer Biochem. Biophys. Res. Commun. 2005, 330 (2) 526-32 (Pubitemid 40417676)
20. Balasubramani, M.; Day, B. W.; Schoen, R. E.; Getzenberg, R. H. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer Cancer Res. 2006, 66 (2) 763-9 (Pubitemid 43165940)
21. Palka, J. A.; Phang, J. M. Prolidase in human breast cancer MCF-7 cells Cancer Lett. 1998, 127 (1-2) 63-70 (Pubitemid 28230786)
22. Winston, J. S.; Asch, H. L.; Zhang, P. J.; Edge, S. B.; Hyland, A.; Asch, B. B. Downregulation of gelsolin correlates with the progression to breast carcinoma Breast Cancer Res. Treat. 2001, 65 (1) 11-21 (Pubitemid 32163495)
23. Danes, C. G.; Wyszomierski, S. L.; Lu, J.; Neal, C. L.; Yang, W.; Yu, D. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling Cancer Res. 2008, 68 (6) 1760-7 (Pubitemid 351416561)
24. Liang, S.; Singh, M.; Gam, L. H. The differential expression of aqueous soluble proteins in breast normal and cancerous tissues in relation to ethnicity of the patients; Chinese, Malay and Indian Dis. Markers 2011, 28 (3) 149-65
25. Neal, C. L.; Yao, J.; Yang, W.; Zhou, X.; Nguyen, N. T.; Lu, J.; Danes, C. G.; Guo, H.; Lan, K. H.; Ensor, J.; Hittelman, W.; Hung, M. C.; Yu, D. 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival Cancer Res. 2009, 69 (8) 3425-32
26. Klopfleisch, R.; Klose, P.; Gruber, A. D. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors Vet. Pathol. 2010, 47 (3) 446-54
27. Klopfleisch, R.; Gruber, A. D. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands Res. Vet. Sci. 2009, 87 (1) 91-6
28. Gay, F.; Estornes, Y.; Saurin, J. C.; Joly-Pharaboz, M. O.; Friederich, E.; Scoazec, J. Y.; Abello, J. In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma Hum. Pathol. 2008, 39 (10) 1420-30
29. Litwin, M.; Mazur, A. J.; Nowak, D.; Mannherz, H. G.; Malicka-Blaszkiewicz, M. Gelsolin in human colon adenocarcinoma cells with different metastatic potential Acta Biochim. Pol. 2009, 56 (4) 739-43
30. Rao, J.; Seligson, D.; Visapaa, H.; Horvath, S.; Eeva, M.; Michel, K.; Pantuck, A.; Belldegrun, A.; Palotie, A. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma Cancer 2002, 95 (6) 1247-57 (Pubitemid 35013059)
31. Fuchs, E. Das Sarkom des Uvealtractus Graefe's Archiv Ophthalmologie 1882, XII (2) 233
32. van 't Veer, L. J.; Dai, H.; van de Vijver, M. J.; He, Y. D.; Hart, A. A.; Mao, M.; Peterse, H. L.; van der Kooy, K.; Marton, M. J.; Witteveen, A. T.; Schreiber, G. J.; Kerkhoven, R. M.; Roberts, C.; Linsley, P. S.; Bernards, R.; Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415 (6871) 530-6 (Pubitemid 34130608)
33. Klopfleisch, R.; Schutze, M.; Gruber, A. D. Downregulation of transforming growth factor beta (TGFbeta) and latent TGFbeta binding protein (LTBP)-4 expression in late stage canine mammary tumours Vet. J. 2010, 186 (3) 379-84
34. Klopfleisch, R.; von Euler, H.; Sarli, G.; Pinho, S. S.; Gartner, F.; Gruber, A. D. Molecular carcinogenesis of canine mammary tumors: news from an old disease Vet. Pathol. 2011, 48 (1) 98-116
35. Ogawa, K.; Utsunomiya, T.; Mimori, K.; Tanaka, Y.; Tanaka, F.; Inoue, H.; Murayama, S.; Mori, M. Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma Br. J. Cancer 2004, 91 (2) 282-6 (Pubitemid 39037073)
36. Mierke, C. T.; Kollmannsberger, P.; Zitterbart, D. P.; Diez, G.; Koch, T. M.; Marg, S.; Ziegler, W. H.; Goldmann, W. H.; Fabry, B. Vinculin facilitates cell invasion into 3D collagen matrices. J. Biol. Chem. 2011, in press.
37. Ricolleau, G.; Charbonnel, C.; Lode, L.; Loussouarn, D.; Joalland, M. P.; Bogumil, R.; Jourdain, S.; Minvielle, S.; Campone, M.; Deporte-Fety, R.; Campion, L.; Jezequel, P. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors Proteomics 2006, 6 (6) 1963-75
38. Bard, M. P.; Hegmans, J. P.; Hemmes, A.; Luider, T. M.; Willemsen, R.; Severijnen, L. A.; van Meerbeeck, J. P.; Burgers, S. A.; Hoogsteden, H. C.; Lambrecht, B. N. Proteomic analysis of exosomes isolated from human malignant pleural effusions Am. J. Respir. Cell Mol. Biol. 2004, 31 (1) 114-21 (Pubitemid 38888047)
39. Krol, M.; Pawlowski, K. M.; Skierski, J.; Rao, N. A.; Hellmen, E.; Mol, J. A.; Motyl, T. Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential J. Physiol. Pharmacol. 2009, 60 (Suppl 1) 95-106
40. Krol, M.; Polanska, J.; Pawlowski, K. M.; Turowski, P.; Skierski, J.; Majewska, A.; Ugorski, M.; Morty, R. E.; Motyl, T. Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs J. Appl. Genet. 2009, 51 (1) 37-50
41. Rao, N. A.; van Wolferen, M. E.; Gracanin, A.; Bhatti, S. F.; Krol, M.; Holstege, F. C.; Mol, J. A. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors J. Physiol. Pharmacol. 2009, 60 (Suppl 1) 73-84
42. Greenbaum, D.; Colangelo, C.; Williams, K.; Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale Genome Biol. 2003, 4 (9) 117